Publication | Closed Access

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematologyPathologyTrioxide-based TherapyAdult T-cell Leukemia-lymphomaPharmacologyPml-rara MutationsCancer ResearchMyeloid Neoplasia